Summary of Purpose
Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.Read More →
The following dates are available for this trial. Trial information last updated on 20 July 2016.
|Unavailable||21 Dec 2007||Unavailable||Unavailable||1 Jul 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|